America’s short-term pause in using Johnson & Johnson’s single-dose Covid-19 vaccine won’t intrude with President Joe Biden’s purpose of getting the nation to some semblance of normalcy by Independence Day, the dean of Brown College’s Faculty of Public Well being mentioned Tuesday.
“I believe that is going to be a blip on the calendar by way of getting Individuals vaccinated,” mentioned Dr. Ashish Jha. “I do not suppose it is going to have an effect on the timeline in any respect.”
Federal well being businesses suggested Tuesday that the U.S. ought to briefly pause using J&J’s single-dose vaccine after six girls out of the roughly 6.9 million individuals who acquired the shot reported getting extreme blood clots. The blood clots occurred in girls between the ages of 18 and 48. One lady died and one other is in crucial situation. All of them developed signs 6 to 13 days after getting the shot, in keeping with the Centers for Disease Control and Prevention and Food and Drug Administration.
Jha advised CNBC’s “The Information with Shepard Smith” that the cautionary measures have been proof that “the system is working,” and that the federal government’s swift motion could counter vaccine hesitancy.